Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.

Guenther G Steger, Daniel Egle, Rupert Bartsch, Georg Pfeiler, Edgar Petru, Richard Greil (Co-author), Ruth Helfgott, Christian Marth, Leopold Öhler, Michael Hubalek, Alois Lang, Christoph Tinchon, Ferdinand Haslbauer, Andreas Redl, Karin Hock, Mathias Hennebelle, Bernhard Mraz, Michael Gnant

    Research output: Contribution to journalOriginal Article (Journal)peer-review

    10 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)64-70
    JournalBREAST
    Volume50
    DOIs
    Publication statusPublished - 2020

    Keywords

    • POSTMENOPAUSAL
    • MANAGEMENT

    Cite this